Doctor Scott Rocklage joined 5AM Venture Management in the year 2003 as a venture partner and has been the managing partner since 2004. He has over thirty years’ experience in the field of healthcare management having served in different facilities. His vast knowledge in the field comes from the service he has provided as the chairman of Nycomed Interventional and the R&D position he held at Salutar and Catalytica.
Dr. Rocklage also served in the capacity of acting CEO at EPIRUS Biopharmaceuticals, Inc. starting out on May, 6th 2016 up until 11th July 2016 when he was appointed on a permanent basis until July 25th, 2016. Generally, Dr. Rocklage has acquired his practical knowledge from the extensive responsibilities he held as a leader in the medical field. He attributes his academic excellence to the University of California where he got his undergraduate degree in B.S Chemistry and his Ph.D. still in Chemistry at the Massachusetts Institute of Technology. While in Massachusetts, he had been working in Richard R. Schrock’s laboratory in his research.
Conducting his research in that laboratory was an honor since Richard was the winner of the 2005 Noble prize in Chemistry. Dr. Rocklage has his offices in Boston.
Scott Rocklage is a household name in the biotechnology world and is respected for research as well as business achievements. 5AM Venture acts as a venture capitalist to companies that are starting up seeing them from the inception stage which is the earliest of stages for companies thus the meaning of the 5AM in the name.
Scott is a hard-working person who has played very vital roles in the growth of the company. Through his tireless efforts in research, Scott has led to the approval of three drugs by the FDA and entered others into clinical trials. Dr. Scott has been behind the invention of approximately 40 patents in the US and has had more than 100 peer-reviewed articles and journals. The success of 5AM Ventures can be attributed to the astounding work of the prominent researcher and his strategic leadership which has made this entrepreneurial venture a success.
For more information, connect with Dr. Scott Rocklage on LinkedIn.